BIO Income Statement
Bio-Rad Laboratories Inc - Revenue, Expenses & Profit Analysis
Stock Price
$278.44
Market Cap
$7.52B
P/E Ratio
10.0
EPS (TTM)
$27.84
Most Recent Quarter
Period: 2025-12-31(2025-12-31)
Revenue
Total sales from operations
$2.58B
+0.7% YoY
Cost of Revenue
Direct costs of sales
$1.24B
Gross Profit
Revenue - Cost of Revenue
$1.34B
Margin: 52.0%
Operating Income
Gross Profit - Operating Expenses
$270.50M
Margin: 0.1%
Interest Expense
Cost of debt
$49.00M
Net Income
Bottom line profit
$759.90M
Margin: 0.3%
Profitability Metrics
Gross Margin
52.0%
Operating Margin
0.1%
Net Margin
0.3%
Return on Equity
0.1%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2025-12-31 | $2.58B | $1.34B | $270.50M | $759.90M | $- |
| 2024-12-31 | $2.57B | $1.38B | $269.00M | $-1.84B | $- |
| 2023-12-31 | $2.67B | $1.43B | $337.80M | $-637.32M | $- |
| 2022-12-31 | $2.80B | $1.57B | $482.62M | $-3.63B | $- |
| 2021-12-31 | $2.92B | $1.64B | $500.34M | $4.25B | $- |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is BIO's revenue?
BIO's most recent quarterly revenue was $2.58B, representing a growth of 0.7% year-over-year.
Is BIO profitable?
BIO reported a profit of $759.90M in the most recent quarter. The net profit margin is 0.3%.
What is BIO's operating income?
BIO's operating income was $270.50M in the most recent quarter. The operating margin is 0.1%.
What is BIO's earnings per share (EPS)?
EPS data is available in the income statement.
What is BIO's gross profit margin?
BIO has a gross profit margin of 52.0%, indicating the profitability of core operations before operating expenses.